In a groundbreaking new study, scientists have developed a synthetic molecule that can effectively ferry mucus-clearing drugs to the lungs. This could be a major breakthrough in treating lung diseases, such as cystic fibrosis, chronic obstructive pulmonary disease and asthma. The team of scientists, led by Professor Xin Wang at the University of Pennsylvania, have created a molecule that binds to mucus and carries drugs directly to the airways. This means that the drugs can be targeted directly to the lungs, reducing the amount of drug required to treat the disease and reducing side effects. This could be a game-changer for people suffering from lung diseases.

Read Full Article Here

source: Phys.org